We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
MSCI
MSCI
$41B
| $146M | 0.06% |
436,996
+24,449
| +6% | +$7.91M |
|
|
HZNP
277
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $145M | 0.06% |
2,616,584
+494,796
| +23% | +$21.2M |
|
278
Kinder Morgan
KMI
$68.8B
| $145M | 0.06% |
9,549,105
-84,083
| -0.9% | -$1.28M |
|
279
Tyson Foods
TSN
$20.4B
| $144M | 0.06% |
2,413,970
-283,439
| -11% | -$17.2M |
|
280
Dollar Tree
DLTR
$25.1B
| $144M | 0.06% |
1,548,667
+146,046
| +10% | +$12.2M |
|
281
Peloton Interactive
PTON
$2.44B
| $143M | 0.06% |
2,472,658
-348,681
| -12% | -$14.4M |
|
282
Xcel Energy
XEL
$48.7B
| $143M | 0.06% |
2,283,648
-87,730
| -4% | -$5.53M |
|
283
Atlassian
TEAM
$38.1B
| $142M | 0.06% |
789,630
+309,127
| +64% | +$51.3M |
|
|
CERN
284
DELISTED
Cerner Corp
CERN
| $141M | 0.06% |
2,056,845
-17,691
| -0.9% | -$1.22M |
|
285
General Dynamics
GD
$106B
| $141M | 0.06% |
940,529
-114,834
| -11% | -$16.2M |
|
286
State Street
STT
$50.9B
| $140M | 0.06% |
2,195,266
-69,530
| -3% | -$4.2M |
|
287
Cintas
CTAS
$81.3B
| $139M | 0.06% |
2,088,088
-112
| -0% | -$6.48K |
|
|
MPT
288
Medical Properties Trust
MPT
$2.82B
| $138M | 0.06% |
7,316,392
+423,930
| +6% | +$7.51M |
|
289
Timken Company
TKR
$8.99B
| $136M | 0.06% |
2,983,841
+2,580,492
| +640% | +$102M |
|
|
ALXN
290
DELISTED
Alexion Pharmaceuticals
ALXN
| $135M | 0.05% |
1,198,878
-288,885
| -19% | -$30.7M |
|
291
Regency Centers
REG
$14.1B
| $134M | 0.05% |
2,911,656
+881,939
| +43% | +$37.3M |
|
292
VICI Properties
VICI
$29.4B
| $133M | 0.05% |
6,610,277
+2,226,076
| +51% | +$40.8M |
|
293
STAG Industrial
STAG
$7.15B
| $133M | 0.05% |
4,543,271
-2,504,432
| -36% | -$65.9M |
|
294
FedEx
FDX
$75.4B
| $133M | 0.05% |
949,561
+25,663
| +3% | +$3.23M |
|
|
WBA
295
DELISTED
Walgreens Boots Alliance
WBA
| $132M | 0.05% |
3,113,681
-178,239
| -5% | -$7.57M |
|
296
Workday
WDAY
$44.2B
| $132M | 0.05% |
703,644
-35,637
| -5% | -$5.76M |
|
297
Amphenol
APH
$207B
| $131M | 0.05% |
5,483,328
+563,844
| +11% | +$12.6M |
|
298
Teledyne Technologies
TDY
$31.9B
| $131M | 0.05% |
421,029
+106,868
| +34% | +$35.1M |
|
299
Corteva
CTVA
$51.5B
| $131M | 0.05% |
4,872,367
-54,702
| -1% | -$1.42M |
|
300
Eversource Energy
ES
$27.3B
| $130M | 0.05% |
1,562,772
+295,576
| +23% | +$24.5M |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.